Ciprofibrate

Ciprofibrate
Clinical data
AHFS/Drugs	International Drug Names
ATC code	C10AB08(WHO);
Identifiers
	IUPAC name (RS)-2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-; methylpropanoic acid;
CAS Number	52214-84-3;
PubChemCID	2763;
IUPHAR/BPS	3438;
ChemSpider	2661;
UNII	F8252JGO9S;
KEGG	D03521;
ChEBI	CHEBI:50867;
ChEMBL	ChEMBL557555;
CompTox Dashboard(EPA)	DTXSID8020331;
ECHA InfoCard	100.052.478
Chemical and physical data
Formula	C13H14Cl2O3
Molar mass	289.15g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES ClC2(Cl)CC2c1ccc(OC(C(=O)O)(C)C)cc1;
	InChI InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17); Key:KPSRODZRAIWAKH-UHFFFAOYSA-N;
	(verify)

Ciprofibrateis afibratethat was developed as alipid-lowering agent.

It was patented in 1972 and approved for medical use in 1985.^[1]

References

^Fischer J, Ganellin CR (2006).Analogue-based Drug Discovery.John Wiley & Sons. p. 474.ISBN 9783527607495.

Thisdrugarticle relating to thecardiovascular systemis astub.You can help Wikipedia byexpanding it.

[Fis2006-1] Fischer J, Ganellin CR (2006).Analogue-based Drug Discovery.John Wiley & Sons. p. 474.ISBN 9783527607495.

[1]

v t e PPARTooltip Peroxisome proliferator-activated receptormodulators
PPARαTooltip Peroxisome proliferator-activated receptor Alpha	Agonists:15-HETE 15-HpETE Aleglitazar Aluminium clofibrate Arachidonic acid Bezafibrate Chiglitazar Clofibrate CP-775146 Daidzein DHEA(prasterone) (in rodents) Elafibranor Etomoxir Fenofibrate Genistein Gemfibrozil GW-7647 Lanifibranor Leukotriene B₄ LG-101506 LG-100754 Lobeglitazone Muraglitazar Oleylethanolamide Palmitoylethanolamide Pemafibrate Perfluorononanoic acid Perfluorooctanoic acid Pioglitazone Saroglitazar Sodelglitazar Tesaglitazar Tetradecylthioacetic acid Troglitazone WY-14643 Antagonists:GW-6471 MK-886
PPARδTooltip Peroxisome proliferator-activated receptor delta	Agonists:15-HETE 15-HpETE Arachidonic acid Bezafibrate Daidzein Elafibranor Fonadelpar Genistein GW-0742 GW-501516 L-165,041 Lanifibranor LG-101506 Seladelpar Sodelglitazar Tetradecylthioacetic acid Antagonists:FH-535 GSK-0660 GSK-3787
PPARγTooltip Peroxisome proliferator-activated receptor gamma	Agonists:5-Oxo-ETE 5-Oxo-15-hydroxy-ETE 15-Deoxy-Δ^12,14-prostaglandin J₂ 15-HETE 15-HpETE Aleglitazar Arachidonic acid Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone Daidzein Darglitazone Edaglitazone Efatutazone Englitazone Etalocib Farglitazar Genistein GW-1929 Ibuprofen Imiglitazar Indeglitazar Lanifibranor LG-100268 LG-100754 LG-101506 Lobeglitazone Muraglitazar (muroglitazar) nTZDpa Naveglitazar Netoglitazone Oxeglitazar Peliglitazar Pemaglitazar Perfluorononanoic acid Pioglitazone Prostaglandin J₂ Ragaglitazar Reglitazar Rivoglitazone Rosiglitazone RS5444 Saroglitazar Sipoglitazar Sodelglitazar Telmisartan Tesaglitazar Troglitazone SPPARMsTooltip Selective PPARγ modulator:BADGE EPI-001 INT-131 MK-0533 S26948 Antagonists:FH-535 GW-9662 SR-202 T-0070907 Unknown:SR-1664
Non-selective	Agonists:Ciprofibrate Clinofibrate Clofibride Englitazone Etofibrate Farglitazar Netoglitazone Ronifibrate Rivoglitazone Simfibrate
See also Receptor/signaling modulators